Vimarsana
Biggest News Aggregation in the World

Page 4 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commodore Capital Today - Breaking & Trending Today

Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week - Vimarsana News

Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week

Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...

Source: yahoo.com
11 Most Promising Psychedelic Stocks According to Hedge Funds - Vimarsana News

11 Most Promising Psychedelic Stocks According to Hedge Funds

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]

Source: yahoo.com
11 Most Promising Psychedelic Stocks According to Hedge Funds - Vimarsana News

11 Most Promising Psychedelic Stocks According to Hedge Funds

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.

Latest biotech news: fundraises, deals, clinical trials - Vimarsana News

Latest biotech news: fundraises, deals, clinical trials

What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

Commodore Capital LP Has $52.26 Million Holdings in Ambrx Biopharma Inc. (NYSE:AMAM) - Vimarsana News

Commodore Capital LP Has $52.26 Million Holdings in Ambrx Biopharma Inc. (NYSE:AMAM)

Commodore Capital LP lowered its position in shares of Ambrx Biopharma Inc. (NYSE:AMAM – Free Report) by 33.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,175,000 shares of the company’s stock after selling 1,628,447 shares during the period. […]

Source: wkrb13.com